Literature DB >> 25577545

Serum cortisol concentration in horses with heaves treated with fluticasone proprionate over a 1 year period.

Trohadio Munoz1, Mathilde Leclere1, Daniel Jean1, Jean-Pierre Lavoie2.   

Abstract

The purpose of this study is to measure the effect of long-term administration of inhaled fluticasone proprionate on cortisol concentrations in heaves-affected horses. Eleven horses with heaves were treated with fluticasone at least once daily at dosages required to improve lung function or with antigen avoidance alone for 1 year. Morning serum cortisol was measured before and after 10, 30, 110, 190, 230, 280, and 320 days of treatment. Cortisol was also measured in the afternoon of day 330. Cortisol was significantly lower in the Fluticasone group on days 30, 110, and 190 when compared with the Antigen avoidance group. Cortisol measured on day 330 was also significantly lower in the Fluticasone group. Results indicate that inhaled fluticasone, when administered at therapeutic dosages, can significantly suppress serum cortisol concentrations for 8-24 h. The clinical significance of this finding remains to be ascertained, as no clinical signs were associated with this cortisol suppression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inhaled corticosteroids; Recurrent airway obstruction

Mesh:

Substances:

Year:  2014        PMID: 25577545     DOI: 10.1016/j.rvsc.2014.12.013

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction.

Authors:  J-P Lavoie; M Bullone; N Rodrigues; P Germim; B Albrecht; M von Salis-Soglio
Journal:  Equine Vet J       Date:  2019-04-05       Impact factor: 2.888

2.  Efficacy of inhaled budesonide for the treatment of severe equine asthma.

Authors:  J P Lavoie; M Leclere; N Rodrigues; K R Lemos; C Bourzac; J Lefebvre-Lavoie; G Beauchamp; B Albrecht
Journal:  Equine Vet J       Date:  2018-09-25       Impact factor: 2.888

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.